BUDESONIDE
3TR-ICS-COPD
Approved small_molecule active
Quick answer
BUDESONIDE for Chronic obstructive pulmonary disease (COPD) is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Chronic obstructive pulmonary disease (COPD)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active